SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-17-006707
Filing Date
2017-11-14
Accepted
2017-11-14 16:57:22
Documents
57
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q s108084_10q.htm 10-Q 500385
2 EXHIBIT 31.1 s108084_ex31-1.htm EX-31.1 14506
3 EXHIBIT 32.1 s108084_ex32-1.htm EX-32.1 5995
  Complete submission text file 0001615774-17-006707.txt   3318824

Data Files

Seq Description Document Type Size
4 XBRL PRESENTATION FILE enum-20170930_pre.xml EX-101.PRE 254832
5 XBRL INSTANCE FILE enum-20170930.xml EX-101.INS 542373
6 XBRL SCHEMA FILE enum-20170930.xsd EX-101.SCH 35294
7 XBRL CALCULATION FILE enum-20170930_cal.xml EX-101.CAL 46160
8 XBRL DEFINITION FILE enum-20170930_def.xml EX-101.DEF 176720
9 XBRL LABEL FILE enum-20170930_lab.xml EX-101.LAB 308754
Mailing Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140 (617) 674-1865
Enumeral Biomedical Holdings, Inc. (Filer) CIK: 0001561551 (see all company filings)

IRS No.: 990376434 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55415 | Film No.: 171202565
SIC: 2834 Pharmaceutical Preparations